Breast Cancer

08/06/2022

With a standard approval from the FDA, the HER2-directed antibody drug conjugate can now be used earlier in treatment to delay disease progression.

07/06/2022

원문이 필요해.

A small NYC-led cancer trial has achieved a result reportedly never before seen – the total remission of cancer in all of its patients. To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, wit...

01/03/2022

Though modeling study's estimated rate of 15% is below previous estimates

02/02/2022

Should focus on a tailored, individualized approach that takes into account and balances efficacy and toxicity

26/12/2021

Experts give recommendations on timing of boosters and mammograms.

26/12/2021

Working across disciplines and ongoing research might help

22/12/2021

Half of pretreated patients benefited from nitric oxide synthase inhibitor plus chemo

22/11/2021

sentinel positive 환자도 axillary dissection 하지 않고 수술 후 axillary radiation으로 치료하는 것을 권고하고 있군요.
과거데이터에서는 수술이나 방사선치료나 림프부종의 합병증이 비슷하다고 했었는데 최근에는 그렇지 않다는 연구가 있었나 확인해야 겠군요.
- Mastos comment

New guidelines from ASCO and Ontario Health

21/11/2021

'First Reliable Estimate' of Breast Cancer Metastasis

A massive global meta-analysis provides 'the first reliable estimate' of what proportion of women with breast cancer will go on to develop metastases.

21/11/2021

ADCs

Learn more about the antibody-drug conjugates currently approved as well as those under development for the treatment of HER2-positive breast cancer.

21/11/2021

Liquid biopsy...

Oncologists weigh in on what to consider when using liquid biopsy in monitoring disease progression.